You are here

  • Home
  • Archive
  • Volume 28, Issue Suppl 1
  • 5PSQ-154 Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice as predictors of severe fluoropyrimidine associated toxicity

Article info

Article menu

Download PDFPDF

Section 5: Patient safety and quality assurance
5PSQ-154 Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice as predictors of severe fluoropyrimidine associated toxicity
Free

Authors

Citation

Alvarado Fernández M, Rendón De Lope L, Villalobos Torres L, et al
5PSQ-154 Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice as predictors of severe fluoropyrimidine associated toxicity
European Journal of Hospital Pharmacy 2021;28:A132.

Publication history

  • First published March 14, 2021.
Online issue publication 
March 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.